Registration

JONES PUBLIC AFFAIRS, INC. for THE SAFDAR GROUP (ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES)

Firm
Client
Income
—
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Protecting patients and consumers from counterfeit, substandard and otherwise unsafe medications

LobbyistCovered position, as disclosed
DEBORAH DANUSER New Intern for U.S. Senator Kent Conrad
BERNA DIEHL New —

Pharmacy PHA

Protecting patients and consumers from counterfeit, substandard and otherwise unsafe medications

LobbyistCovered position, as disclosed
DEBORAH DANUSER New Intern for U.S. Senator Kent Conrad
BERNA DIEHL New —

Trade (domestic/foreign) TRD

Protecting patients and consumers from counterfeit, substandard and otherwise unsafe medications

LobbyistCovered position, as disclosed
DEBORAH DANUSER New Intern for U.S. Senator Kent Conrad
BERNA DIEHL New —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.